|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 19702676.8 (espacenet) (Federated) (European Patent Register), 20190123 | Patent/reg. no. and date | DK/EP 3743511, 20230607 | Publication date | 20201202 | Priority no. and date | GB 201801067, 20180123 | EP pub. no. and date |
EP 3743511 20201202 | Effective date | | Applicant/owner | INSTIL BIO (UK) LIMITED, 48 Grafton Street
Manchester M13 9XX, GB | Applicant ref. no. | | Inventor | PRICE, Nicola Kaye, Immetacyte Limited 3 Heald Court 34 Hawthorn Lane
Wilmslow, Cheshire SK9 5DG, GB, BRIDGEMAN, John Stephen, Immetacyte Limited 3 Heald Court 34 Hawthorn Lane
Wilmslow, Cheshire SK9 5DG, GB | Representative | | Opponent | | IPC Class | A61K 35/17 (2015.01) , C12N 5/0783 (2010.01) | Title | BIOMARKER PREDICTIVE OF TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF | Int. application no. | GB2019050188 | Int. publication no. | WO2019145711 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |